SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: December 8, 1998
Date of earliest event reported: December 4, 1998
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware 1-3619 13-5315170
(State or other (Commission File (I.R.S. Employer
jurisdiction of Number) Identification No.)
incorporation)
235 East 42nd Street
New York, New York 10017
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(212) 573-2323
Item 2. Acquisition or Disposition of Assets
The sale of the Howmedica business -- a part of Pfizer Inc.'s Medical
Technology Group -- to Stryker Corporation for $1.65 billion in cash, closed on
December 4, 1998. The sale was a negotiated, arms-length transaction.
With global operations and based in Rutherford, New Jersey, Howmedica
manufactures and sells devices for orthopedic reconstruction, for trauma repair
and for skull and facial surgery. In 1997, Howmedica reported sales of
approximately $820 million.
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the
registrant has caused this report to be signed on its behalf by the authorized
undersigned.
PFIZER INC.
By: /s/ TERENCE J. GALLAGHER
.............................
Name: Terence J. Gallagher
Title: Vice President-
Corporate Governance
Dated: December 8, 1998
